← Leaderboards
Ruth Lupu
University Of Calif-Lawrenc Berkeley Lab
$5,540,890
Attributed
$5,540,890
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $744.8K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,540,890 · 3
By mechanism
R01$5,540,890 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionAngiogenesisResistanceMolecularNormal CellPlayGrowthBreastIn VivoMaintenanceEventClinically RelevantPhenotypeCellsNoninfiltrating Intraductal CarcinomaBreast Cancer CellBreast CarcinomaResponseCancer PatientIn VitroChemotherapyCancer TherapyBaseTissues
Grant awards (17)
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$410,071
R01 · FY2014 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$433,515
R01 · FY2013 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$461,186
R01 · FY2012 · CA · contact PI
Cyr61-induced breast cancer: Clinical relevance and therapeutic development$306,490
R01 · FY2010 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$444,316
R01 · FY2009 · CA · contact PI
Cyr61-induced breast cancer: Clinical relevance and therapeutic development$300,480
R01 · FY2009 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$352,699
R01 · FY2008 · CA · contact PI
Cyr61-induced breast cancer: Clinical relevance and therapeutic development$291,727
R01 · FY2008 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$70,483
R01 · FY2008 · CA · contact PI
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention$418,872
R01 · FY2007 · CA · contact PI
Cyr61-induced breast cancer: Clinical relevance and therapeutic development$284,919
R01 · FY2007 · CA · contact PI
Fatty Acid Synthase: Characterization as a Novel Molecular Target for Breast Can*$418,986
R01 · FY2006 · CA · contact PI
Cyr61-induced breast cancer: Clinical relevance and therapeutic development$284,883
R01 · FY2006 · CA · contact PI
Fatty Acid Synthase /Molecular Target /Breast Cancer The$416,745
R01 · FY2005 · CA
ROLE OF CYR61 IN HEREGULIN OF BREAST CANCER PROGRESSION$212,882
R01 · FY2002 · DK
ROLE OF CYR61 IN HEREGULIN OF BREAST CANCER PROGRESSION$219,290
R01 · FY2001 · DK
ROLE OF CYR61 IN HEREGULIN OF BREAST CANCER PROGRESSION$213,346
R01 · FY2000 · DK